Optiscan Imaging Ltd has released a press release.
OIL breast cancer study to commence next stage - revised
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Optiscan breast cancer study to commence next stage
- OIL December 2020 Quarterly Report and Appendix 4C
- Carl Zeiss Meditec AG Product Orders
- Appointment of Taiwan Distributor
- OIL 2020 AGM Presentation
Later from Optiscan Imaging
- Appendix 4D and Financial Statements - 31 December 2020
- Appointment of New Non-executive Chair
- OIL March 2021 Quarterly Report and Appendix 4C
- Appointment of new non-executive director
- Update on seeking United States FDA approval & market entry
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging